Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bicalutamide
Drug ID BADD_D00271
Description Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. Bicalutamide binds to the androgen receptor.
Indications and Usage For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
Marketing Status Prescription; Discontinued
ATC Code L02BB03
DrugBank ID DB01128
KEGG ID D00961
MeSH ID C053541
PubChem ID 2375
TTD Drug ID D0V9BD
NDC Product Code 60429-177; 70518-2993; 51846-1028; 16714-816; 62559-680; 0904-6019; 16729-023; 43265-0705; 15308-0360; 54893-0001; 49711-1504; 65841-613; 43265-7195; 49711-1509; 71205-577; 68382-224; 47335-485; 63629-8308; 63759-0004; 62559-890; 53104-7664; 46014-1111; 58623-0068
Synonyms bicalutamide | 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide | Casodex | Cosudex | ICI-176334 | ICI 176334
Chemical Information
Molecular Formula C18H14F4N2O4S
CAS Registry Number 90357-06-5
SMILES CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.0110.058000%Not Available
Chills08.01.09.001; 15.05.03.0160.029000%
Cholangitis09.02.01.0020.006444%Not Available
Cholecystitis acute09.03.01.0030.009667%Not Available
Cholelithiasis09.03.01.0020.012889%Not Available
Chorea17.01.01.0010.006444%Not Available
Chromaturia20.02.01.0020.006444%
Chronic obstructive pulmonary disease22.03.01.0070.005884%Not Available
Colitis07.08.01.0010.009667%
Colon cancer16.13.01.001; 07.21.01.0010.007565%Not Available
Coma17.02.09.001--Not Available
Compression fracture15.08.02.004; 12.04.02.0080.012889%Not Available
Confusional state19.13.01.001; 17.02.03.0050.038667%
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Coronary artery disease24.04.04.006; 02.02.01.0010.016111%Not Available
Coronary artery occlusion02.02.01.006; 24.04.04.0130.012889%Not Available
Cough22.02.03.001--
Cushing's syndrome24.08.04.001; 19.07.03.002; 14.11.01.007; 05.01.01.0010.006444%Not Available
Cyst16.02.02.002; 08.03.05.001--Not Available
Cystitis20.03.02.002; 11.01.14.0010.006444%
Death08.04.01.001--
Dehydration14.05.05.0010.070889%
Delirium19.13.02.0010.009667%
Delusion19.10.01.0010.009667%
Dementia Alzheimer's type19.20.03.001; 17.03.06.0010.309334%Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diabetes mellitus05.06.01.001; 14.06.01.0010.025778%Not Available
Diabetic ketoacidosis05.07.03.001; 14.07.03.001--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 17 Pages